Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kosmix was a semantic search and web categorization company that significantly impacted the digital health landscape through its flagship product, RightHealth. The company developed a proprietary platform called "Genome"—a massive knowledge graph that organized the internet into millions of interconnected topic pages, providing a structured alternative to traditional keyword search. RightHealth leveraged this technology to aggregate and categorize medical information from diverse sources, becoming one of the most visited health sites globally. In 2011, Kosmix was acquired by Walmart for approximately $300 million to form the foundation of @WalmartLabs. The acquisition shifted the company's focus toward social commerce and retail analytics, integrating its semantic technology into Walmart's e-commerce ecosystem. While not a traditional biotechnology firm, Kosmix's innovative use of semantic data revolutionized how consumers accessed and navigated complex healthcare information online.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kosmix.